Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Crinetics Pharmaceuticals — Total assets by Quarter
Crinetics Pharmaceuticals — Total assets ($M) ($M)
Vertex Pharmaceuticals Crinetics Pharmaceuticals — Total assets: $1,322M in Q2 2026, up 2.5% from a year earlier.
Where the Q2 2026 figure comes from
Source: SEC Filing ↗
Reported in SEC XBRL (CIK 0001699813 Crinetics Pharmaceuticals).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Crinetics Pharmaceuticals — Total assets ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 1,322 | +2.5% | SEC Filing ↗ |
| Q1 2026 | Mar 31, 2026 | 1,401 | +2.9% | SEC Filing ↗ |
| Q4 2025 | Dec 31, 2025 | 1,126 | -21.5% | SEC Filing ↗ |
| Q3 2025 | Sep 30, 2025 | 1,196 | +27.6% | SEC Filing ↗ |
| Q2 2025 | Jun 30, 2025 | 1,290 | +37.8% | SEC Filing ↗ |
| Q1 2025 | Mar 31, 2025 | 1,361 | +39.2% | SEC Filing ↗ |
| Q4 2024 | Dec 31, 2024 | 1,435 | +125.8% | SEC Filing ↗ |
| Q3 2024 | Sep 30, 2024 | 937 | +46.1% | SEC Filing ↗ |
| Q2 2024 | Jun 30, 2024 | 936 | +219.0% | SEC Filing ↗ |
| Q1 2024 | Mar 31, 2024 | 978 | +211.5% | SEC Filing ↗ |
| Q4 2023 | Dec 31, 2023 | 635 | +80.4% | SEC Filing ↗ |
| Q3 2023 | Sep 30, 2023 | 642 | +66.7% | SEC Filing ↗ |
| Q2 2023 | Jun 30, 2023 | 293 | -30.5% | SEC Filing ↗ |
| Q1 2023 | Mar 31, 2023 | 314 | -5.8% | SEC Filing ↗ |
| Q4 2022 | Dec 31, 2022 | 352 | +0.3% | SEC Filing ↗ |
| Q3 2022 | Sep 30, 2022 | 385 | +83.8% | SEC Filing ↗ |
| Q2 2022 | Jun 30, 2022 | 422 | +94.4% | SEC Filing ↗ |
| Q1 2022 | Mar 31, 2022 | 333 | +103.8% | SEC Filing ↗ |
| Q4 2021 | Dec 31, 2021 | 351 | +91.3% | SEC Filing ↗ |
| Q3 2021 | Sep 30, 2021 | 209 | +4.5% | SEC Filing ↗ |
| Q2 2021 | Jun 30, 2021 | 217 | -0.1% | SEC Filing ↗ |
| Q1 2021 | Mar 31, 2021 | 164 | +32.0% | SEC Filing ↗ |
| Q4 2020 | Dec 31, 2020 | 183 | +40.7% | SEC Filing ↗ |
| Q3 2020 | Sep 30, 2020 | 200 | +40.6% | SEC Filing ↗ |
| Q2 2020 | Jun 30, 2020 | 217 | +39.9% | SEC Filing ↗ |
| Q1 2020 | Mar 31, 2020 | 124 | -25.7% | SEC Filing ↗ |
| Q4 2019 | Dec 31, 2019 | 130 | -23.9% | SEC Filing ↗ |
| Q3 2019 | Sep 30, 2019 | 143 | -19.3% | SEC Filing ↗ |
| Q2 2019 | Jun 30, 2019 | 155 | +107.7% | SEC Filing ↗ |
| Q1 2019 | Mar 31, 2019 | 167 | – | SEC Filing ↗ |
| Q4 2018 | Dec 31, 2018 | 171 | – | SEC Filing ↗ |
| Q3 2018 | Sep 30, 2018 | 177 | – | SEC Filing ↗ |
| Q2 2018 | Jun 30, 2018 | 74.7 | – | SEC Filing ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Crinetics Pharmaceuticals — Total assets ($M), quarterly Q2 2018–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/crinetics-assets
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.